Antibiotic Prophylaxis in Functional Endoscopic Sinus Surgery (FESS)
Antibiotic prophylaxis is not routinely recommended for FESS, as it is classified as clean-contaminated surgery with expected infection rates below 5%, and high-quality evidence shows that postoperative antibiotics do not improve outcomes or reduce bacterial growth after FESS. 1
Evidence Against Routine Prophylaxis
The strongest direct evidence comes from a randomized controlled trial specifically evaluating postoperative antibiotic use after FESS. This study demonstrated that:
- Postoperative amoxicillin/clavulanate for 3 weeks after FESS did not improve symptom scores, endoscopic findings, or decrease bacterial growth compared to no antibiotics 1
- Both groups showed significant symptom improvement after surgery regardless of antibiotic use 1
- No differences were found in bacterial culture rates or outcomes between antibiotic and control groups at 3 weeks post-FESS 1
Guideline Framework for Clean-Contaminated Surgery
International surgical prophylaxis guidelines provide the broader context for FESS:
- For clean-contaminated ENT surgery with oropharyngeal opening (primarily neoplastic surgery), antibiotic prophylaxis is indicated due to high infection risk (~30%) 2
- However, standard FESS without extensive mucosal resection or oropharyngeal communication does not fall into this high-risk category 2
- When prophylaxis is indicated for ENT procedures, duration should not exceed 24 hours, as this represents prophylaxis rather than curative therapy 2
When Prophylaxis May Be Considered
If you decide to use prophylaxis in specific high-risk FESS cases, follow this protocol:
- Target organisms: Streptococcus, anaerobes, S. aureus, K. pneumoniae, E. coli 2
- First-line agent: Amoxicillin/clavulanate based on local microbial patterns 3
- Timing: Single dose within 30-60 minutes before incision 2, 4
- Duration: Discontinue within 24 hours postoperatively 5, 6
- Do not extend antibiotics beyond 24 hours even if drains are present 5
Microbiology Considerations
Recent microbiological data from CRS patients undergoing FESS shows:
- Most common pathogens: Peptostreptococcus spp., Propionibacterium spp., S. aureus, Pseudomonas spp., Fusobacterium spp., and H. influenzae 3
- Amoxicillin-clavulanic acid demonstrates appropriate coverage based on antibiotic susceptibility patterns 3
- Metronidazole cannot be recommended due to high resistance rates among anaerobic isolates 3
Critical Pitfalls to Avoid
- Do not routinely prescribe postoperative antibiotics for standard FESS, as this provides no benefit and increases antimicrobial resistance 1, 7
- Do not confuse prophylaxis with therapeutic antibiotics—if postoperative infection develops with fever ≥38.5°C, cellulitis >5cm, or systemic signs, this requires treatment, not prophylaxis 8
- Extending antibiotics beyond 24 hours does not reduce infection rates but increases C. difficile infection, antimicrobial resistance, hypersensitivity reactions, and renal failure 5
When Therapeutic Antibiotics Are Indicated
Postoperative antibiotics are only warranted if true surgical site infection develops: